Citigroup
BTCY

Citigroup’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Citigroup’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-80
Closed -$1K – 6450
2022
Q2 		$1K Buy
+80
New +$698 ﹤0.01% 6127

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return

Citigroup's BTCY Position: Q3 2022 in Review

Citigroup sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2022, closing a stake of 80 shares — an estimated $1K sold.

Citigroup first reported a position in BTCY in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 29 funds tracked by Wall St. Rank hold BTCY as of Q3 2022.

  • Citigroup reported no remaining Biotricity, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 80 Biotricity, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Biotricity, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Citigroup's Biotricity, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.